# Texas Pacific Land Corp: financial statements, quarterly

TPL · NYSE · CIK 1811074 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tpl.md) · [Financials](/companies/tpl/financials.md) · [Filings](/companies/tpl/filings.md) · [Insiders](/companies/tpl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tpl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [158](/filings/0001811074-24-000061.md) | [167 d](/filings/0001811074-26-000018.md) | [174](/filings/0001811074-25-000060.md) | [172](/filings/0001811074-25-000077.md) | [174](/filings/0001811074-25-000096.md) | [186 d](/filings/0001811074-26-000018.md) | [196](/filings/0001811074-26-000035.md) | [188](/filings/0001811074-26-000058.md) | [203](/filings/0001811074-25-000096.md) | [212 d](/filings/0001811074-26-000018.md) | [237](/filings/0001811074-26-000035.md) | [246](/filings/0001811074-26-000058.md) |
| Operating income | $m | [127](/filings/0001811074-24-000061.md) | [134 d](/filings/0001811074-26-000018.md) | [136](/filings/0001811074-25-000060.md) | [133](/filings/0001811074-25-000077.md) | [127](/filings/0001811074-25-000096.md) | [143 d](/filings/0001811074-26-000018.md) | [150](/filings/0001811074-26-000035.md) | [144](/filings/0001811074-26-000058.md) | [149](/filings/0001811074-25-000096.md) | [149 d](/filings/0001811074-26-000018.md) | [182](/filings/0001811074-26-000035.md) | [192](/filings/0001811074-26-000058.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001811074-26-000035.md) | [0.0](/filings/0001811074-26-000058.md) | not reported | not reported | [1.0](/filings/0001811074-26-000035.md) | [1.0](/filings/0001811074-26-000058.md) |
| Income tax | $m | [29.4](/filings/0001811074-24-000061.md) | [32.0 d](/filings/0001811074-26-000018.md) | [31.6](/filings/0001811074-25-000060.md) | [31.9](/filings/0001811074-25-000077.md) | [28.8](/filings/0001811074-25-000096.md) | [32.6 d](/filings/0001811074-26-000018.md) | [33.7](/filings/0001811074-26-000035.md) | [32.9](/filings/0001811074-26-000058.md) | [33.9](/filings/0001811074-25-000096.md) | [28.4 d](/filings/0001811074-26-000018.md) | [40.7](/filings/0001811074-26-000035.md) | [39.8](/filings/0001811074-26-000058.md) |
| Net income | $m | [106](/filings/0001811074-24-000061.md) | [113 d](/filings/0001811074-26-000018.md) | [114](/filings/0001811074-25-000096.md) | [115](/filings/0001811074-25-000096.md) | [107](/filings/0001811074-25-000096.md) | [118 d](/filings/0001811074-26-000018.md) | [121](/filings/0001811074-26-000058.md) | [116](/filings/0001811074-26-000058.md) | [121](/filings/0001811074-25-000096.md) | [123 d](/filings/0001811074-26-000018.md) | [143](/filings/0001811074-26-000058.md) | [154](/filings/0001811074-26-000058.md) |
| Diluted EPS | $ per share | [4.58](/filings/0001811074-24-000061.md) | not reported | [4.97](/filings/0001811074-25-000060.md) | [4.98](/filings/0001811074-25-000077.md) | [4.63](/filings/0001811074-25-000096.md) | not reported | [1.75](/filings/0001811074-26-000035.md) | [1.68](/filings/0001811074-26-000058.md) | [5.27](/filings/0001811074-25-000096.md) | not reported | [2.07](/filings/0001811074-26-000035.md) | [2.23](/filings/0001811074-26-000058.md) |
| Basic EPS | $ per share | [4.58](/filings/0001811074-24-000061.md) | not reported | [4.97](/filings/0001811074-25-000060.md) | [4.99](/filings/0001811074-25-000077.md) | [4.64](/filings/0001811074-25-000096.md) | not reported | [1.75](/filings/0001811074-26-000035.md) | [1.68](/filings/0001811074-26-000058.md) | [5.27](/filings/0001811074-25-000096.md) | not reported | [2.07](/filings/0001811074-26-000035.md) | [2.23](/filings/0001811074-26-000058.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [654](/filings/0001811074-23-000053.md) | [725](/filings/0001811074-25-000044.md) | [837](/filings/0001811074-24-000031.md) | [895](/filings/0001811074-24-000049.md) | [534](/filings/0001811074-24-000061.md) | [370](/filings/0001811074-26-000018.md) | [460](/filings/0001811074-25-000060.md) | [544](/filings/0001811074-25-000077.md) | [532](/filings/0001811074-25-000096.md) | [145](/filings/0001811074-26-000058.md) | [248](/filings/0001811074-26-000035.md) | [249](/filings/0001811074-26-000058.md) |
| Current assets | $m | [791](/filings/0001811074-23-000053.md) | [862](/filings/0001811074-25-000044.md) | [964](/filings/0001811074-24-000031.md) | [1,018](/filings/0001811074-24-000049.md) | [709](/filings/0001811074-24-000061.md) | [503](/filings/0001811074-26-000018.md) | [607](/filings/0001811074-25-000060.md) | [668](/filings/0001811074-25-000077.md) | [737](/filings/0001811074-25-000096.md) | [319](/filings/0001811074-26-000058.md) | [435](/filings/0001811074-26-000035.md) | [428](/filings/0001811074-26-000058.md) |
| Total assets | $m | [1,079](/filings/0001811074-23-000053.md) | [1,156](/filings/0001811074-25-000044.md) | [1,259](/filings/0001811074-24-000031.md) | [1,316](/filings/0001811074-24-000049.md) | [1,176](/filings/0001811074-24-000061.md) | [1,248](/filings/0001811074-26-000018.md) | [1,353](/filings/0001811074-25-000060.md) | [1,405](/filings/0001811074-25-000077.md) | [1,525](/filings/0001811074-25-000096.md) | [1,623](/filings/0001811074-26-000058.md) | [1,751](/filings/0001811074-26-000035.md) | [1,859](/filings/0001811074-26-000058.md) |
| Current liabilities | $m | [47.4](/filings/0001811074-23-000053.md) | [44.4](/filings/0001811074-25-000044.md) | [70.9](/filings/0001811074-24-000031.md) | [44.3](/filings/0001811074-24-000049.md) | [57.3](/filings/0001811074-24-000061.md) | [46.6](/filings/0001811074-26-000018.md) | [77.9](/filings/0001811074-25-000060.md) | [45.1](/filings/0001811074-25-000077.md) | [67.9](/filings/0001811074-25-000096.md) | [72.6](/filings/0001811074-26-000058.md) | [103](/filings/0001811074-26-000035.md) | [94.1](/filings/0001811074-26-000058.md) |
| Total liabilities | $m | [115](/filings/0001811074-23-000053.md) | [113](/filings/0001811074-25-000044.md) | [137](/filings/0001811074-24-000031.md) | [109](/filings/0001811074-24-000049.md) | [123](/filings/0001811074-24-000061.md) | [116](/filings/0001811074-26-000018.md) | [147](/filings/0001811074-25-000060.md) | [116](/filings/0001811074-25-000077.md) | [157](/filings/0001811074-25-000096.md) | [164](/filings/0001811074-26-000058.md) | [196](/filings/0001811074-26-000035.md) | [187](/filings/0001811074-26-000058.md) |
| Shareholders' equity | $m | [965](/filings/0001811074-24-000061.md) | [1,043](/filings/0001811074-26-000018.md) | [1,122](/filings/0001811074-25-000096.md) | [1,206](/filings/0001811074-25-000096.md) | [1,052](/filings/0001811074-25-000096.md) | [1,132](/filings/0001811074-26-000058.md) | [1,206](/filings/0001811074-26-000058.md) | [1,289](/filings/0001811074-26-000058.md) | [1,368](/filings/0001811074-25-000096.md) | [1,459](/filings/0001811074-26-000058.md) | [1,556](/filings/0001811074-26-000058.md) | [1,672](/filings/0001811074-26-000058.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [108 d](/filings/0001811074-24-000061.md) | [111 d](/filings/0001811074-26-000018.md) | [147](/filings/0001811074-25-000060.md) | [98.3 d](/filings/0001811074-25-000077.md) | [119 d](/filings/0001811074-25-000096.md) | [127 d](/filings/0001811074-26-000018.md) | [157](/filings/0001811074-26-000035.md) | [121 d](/filings/0001811074-26-000058.md) | [155 d](/filings/0001811074-25-000096.md) | [114 d](/filings/0001811074-26-000018.md) | [162](/filings/0001811074-26-000035.md) | [173 d](/filings/0001811074-26-000058.md) |
| Capital expenditure | $m | [5.2](/filings/0001811074-23-000053.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [25.0 d](/filings/0001811074-24-000061.md) | [25.0 d](/filings/0001811074-26-000018.md) | [26.9](/filings/0001811074-25-000060.md) | [26.9 d](/filings/0001811074-25-000077.md) | [257 d](/filings/0001811074-25-000096.md) | [36.8 d](/filings/0001811074-26-000018.md) | [37.4](/filings/0001811074-26-000035.md) | [36.8 d](/filings/0001811074-26-000058.md) | [36.8 d](/filings/0001811074-25-000096.md) | [36.8 d](/filings/0001811074-26-000018.md) | [41.8](/filings/0001811074-26-000035.md) | [41.4 d](/filings/0001811074-26-000058.md) |
| Share repurchases | $m | [5.9 d](/filings/0001811074-24-000061.md) | [10.2 d](/filings/0001811074-26-000018.md) | [10.3](/filings/0001811074-25-000060.md) | [6.4 d](/filings/0001811074-25-000077.md) | [6.1 d](/filings/0001811074-25-000096.md) | [6.4 d](/filings/0001811074-26-000018.md) | [0.1](/filings/0001811074-26-000035.md) | [0.0 d](/filings/0001811074-26-000058.md) | [8.3 d](/filings/0001811074-25-000096.md) | [0.0 d](/filings/0001811074-26-000018.md) | [0.0](/filings/0001811074-26-000035.md) | [0.0 d](/filings/0001811074-26-000058.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.7](/filings/0001811074-23-000053.md) | [23.1](/filings/0001811074-24-000031.md) | [23.1](/filings/0001811074-24-000049.md) | [23.0](/filings/0001811074-24-000061.md) | [23.0](/filings/0001811074-25-000060.md) | [23.0](/filings/0001811074-25-000077.md) | [23.0](/filings/0001811074-25-000096.md) | [69.0](/filings/0001811074-26-000035.md) | [69.0](/filings/0001811074-26-000058.md) | [23.0](/filings/0001811074-25-000096.md) | [69.0](/filings/0001811074-26-000035.md) | [69.0](/filings/0001811074-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,974,683 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001811074-26-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.